Rapid Progressors in Alzheimer's Disease: Implications for Symptomatic Clinical Trial Design
This study reveals significant differences between RPs and SPs in various clinical, imaging, and biochemical markers, highlighting the interplay of factors influencing AD progression. The results show the need for tailored approaches to clinical trials to account for different progression patterns within AD.
Authors
- Kristofer Harris (ORCID: https://orcid.org/0000-0003-1250-6650)
- Madison Shyer (ORCID: https://orcid.org/0000-0002-8166-1868)
- Dulin Wang (ORCID: https://orcid.org/0000-0003-1574-2093)
- Paul Ernest Schulz (ORCID: https://orcid.org/0000-0003-0676-002X)
- Xiaoqian Jiang
- Yejin Kim
Institutions
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_101271
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00